Articles from Avance Clinical

ADELAIDE, Australia, Jan. 09, 2026 (GLOBE NEWSWIRE) -- Avance Clinical, the award-winning Australian led, global CRO built exclusively to service the clinical research needs of biotech companies, announced today that its executive team will attend Biotech Showcase 2026 in San Francisco, January 12-14, to meet with innovative biotech sponsors and highlight the company’s newly launched Early Phase Center of Excellence for Biotechs.

ADELAIDE, Australia, Jan. 07, 2026 (GLOBE NEWSWIRE) -- Avance Clinical, a global contract research organization focused on accelerating clinical development for biotech sponsors, today announced the acquisition of LumaBridge, a specialized U.S.-based clinical CRO with deep expertise in oncology trials. This strategic acquisition expands Avance’s existing U.S. presence and marks a significant milestone in accelerating the company’s growth in oncology, the largest and fastest-growing therapeutic area in global R&D. Both organizations share a commitment to deliver high quality, innovative and efficient oncology clinical trials that accelerate the development of next-generation therapies to patients worldwide.

ADELAIDE, Australia, Dec. 10, 2025 (GLOBE NEWSWIRE) -- Avance Clinical, the award-winning global CRO for biotechs, has announced the launch of its new Diversity in STEM Scholarships, a global initiative designed to support women and minority-group students pursuing careers in science, technology, engineering, and mathematics (STEM). The program includes dedicated intakes in Australia and the broader Asia-Pacific region, as well as North America, reinforcing the company’s commitment to equity and inclusion in clinical research.

ADELAIDE, Australia, Oct. 30, 2025 (GLOBE NEWSWIRE) -- Avance Clinical, a partner for biotechs providing global contract research organization services, has announced the launch of the Renal & Cardiometabolic Center of Excellence. The center is built to speed up clinical development by including therapeutic leaders early in design, bolstering patient recruitment and retention, and guiding studies from protocol through closeout.

ADELAIDE, Australia, Oct. 28, 2025 (GLOBE NEWSWIRE) -- Avance Clinical, the award-winning Australian led, global CRO built exclusively to service the clinical research needs of biotech companies, today announced the launch of its Center of Excellence dedicated to central nervous system (CNS) disorders. This strategic initiative addresses the unique clinical trial execution challenges facing biotech companies developing neurological therapies, offering integrated solutions from first-in-human studies through Phase III trials.

ADELAIDE, Australia, Oct. 20, 2025 (GLOBE NEWSWIRE) -- Avance Clinical, the Australia-based global CRO partner for biotechs, has been a leader in early phase clinical research for more than 30 years. With operations across Australia, New Zealand, North America, Asia, and Europe, the company delivers biotech sponsors both deep local expertise and global reach. Expanding on this legacy, Avance Clinical today announced the launch of its dedicated Early Phase Center of Excellence for Biotechs, designed to deliver scientific rigor, innovative trial design, global regulatory insight, and operational excellence for smarter, more efficient early phase trials with significant cost savings for global biotechs.

Avance Clinical, a partner for biotechs providing global contract research organization services, has now guided 710 emerging biotechs through critical clinical trial inflection points.

ADELAIDE, Australia, May 26, 2025 (GLOBE NEWSWIRE) -- As regulatory uncertainty grows in the United States, US biotechs are increasingly looking to Australia as a stable and predictable launchpad for early-phase clinical trials. With its globally accepted regulatory framework, accelerated timelines, and 43.5% R&D rebate, Australia offers a compelling advantage — and Avance Clinical, Australia’s leading early-phase specialist CRO, is delivering the GlobalReady solution to help biotechs de-risk, conserve capital and accelerate their programs.

ADELAIDE, Australia and BOSTON, May 07, 2025 (GLOBE NEWSWIRE) -- Avance Clinical, the award-winning, global CRO for biotechs, is proud to announce its sponsorship of the Citeline Awards 2025, to be held in Boston tomorrow, May 8, 2025. Recognized as a premier celebration of innovation and excellence in clinical R&D, the Citeline Awards honor the most significant achievements across the global biopharma industry.

MERTHYR TYDFIL, United Kingdom and ADELAIDE, Australia, Feb. 24, 2025 (GLOBE NEWSWIRE) -- Simbec-Orion and Avance Clinical are thrilled to announce the signing of a Memorandum of Understanding (MOU), marking a significant milestone in their strategic partnership. This formal agreement establishes a collaborative framework between two like-minded, full-service Contract Research Organizations (CROs), united by their shared commitment to high-quality, agile service delivery. Together, the partnership offers a seamless, globally integrated solution for clinical trial execution, enabling biotech and pharmaceutical companies to access unparalleled expertise and resources worldwide.

WAKE FOREST, N.C. and ADELAIDE, Australia, Jan. 13, 2025 (GLOBE NEWSWIRE) -- Avance Clinical, a leading full-service global Contract Research Organization (CRO) known for delivering high-quality, agile clinical research services, is proud to announce it is the CRO of choice for early phase clinical trials in Australia with more than 52% of market share.

WAKE FOREST, N.C. and ADELAIDE, Australia , Oct. 29, 2024 (GLOBE NEWSWIRE) -- Avance Clinical, a leading full-service global Contract Research Organization (CRO) known for delivering high-quality, agile clinical research services, is proud to announce the signing of three significant Memorandums of Understanding (MOUs) with key Korean clinical sites during KoNECT 2024 conference.

WAKE FOREST, N.C. and ADELAIDE, Australia, Sept. 13, 2024 (GLOBE NEWSWIRE) -- Avance Clinical, the market-leading CRO for biotechs, announced today that Avance Clinical will represent the CRO sector at the Australian Clinical Trials Roadshow (September 17-20) to share the unparalleled time, cost and quality opportunities for early phase US biotechs.

WAKE FOREST, N.C. and ADELAIDE, Australia , Sept. 01, 2024 (GLOBE NEWSWIRE) -- Avance Clinical, the award-winning market-leading CRO for biotechs, announced today that 2,000 clinical sites across North America had joined the Avance Clinical GlobalReady Site Partnership Network.

ADELAIDE, Australia and WAKE FOREST, N.C., Aug. 27, 2024 (GLOBE NEWSWIRE) -- Avance Clinical, a leading global CRO specializing in clinical trials for the biotech sector, has won the prestigious 2024 Frost & Sullivan Best Practices Customer Value Leadership Award for Global Biotech CRO Excellence.

ADELAIDE, Australia and WAKE FOREST, N.C., July 31, 2024 (GLOBE NEWSWIRE) -- Avance Clinical, an award-winning, mid-sized full-service global Contract Research Organization (CRO) for biotech companies, is pleased to announce the appointment of Jeanne Schow as Senior Vice President, Business Development. Jeanne will be based out of the San Francisco Bay Area.